National follow-up group of children with idiopathic nephrotic syndrome
Follows children with idiopathic nephrotic syndrome to study their course and support future trials.
Key facts
- Who runs it
- University Hospital, Limoges
- Where
- France and Réunion48 sites in 2 countriesChoose a country to see its sites
- Trial code
- Registry title
- A National Prospective Cohort of Patients With Idiopathic Nephrotic Syndrome Beginning in Childhood.
- Status
- Recruiting
- People taking part
- 1,180 people, planned
- Started
- 13 Mar 2020
- Expected to end
- Jan 2048
- Type of study
- Observational
- Treatments tested
- Inclusion and follow up of pediatric patients with an idiopathic nephrotic syndrome,
- Record updated
- 13 March 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children and teens with idiopathic nephrotic syndrome (a kidney disease that makes the body lose protein in urine, with no known cause). It follows them over time in France.
- Age
- Under 18 years
- Sex
- All
- Disease stage
- Idiopathic nephrotic syndrome (by SPN criteria) that started after January 1, 2018.
Main reasons for not taking part
- The patient or their legal representatives refuse to take part
- Not living in France
- Not seen at least once by a pediatrician member of the Society of Pediatric Nephrology
- Not covered by a social security system
The registry criteria, word for word
Show all 7 criteriaShow less
Who can take part
- Patient under 18 years of age
- With idiopathic nephrotic syndrome (according to SPN criteria) beginning after January 1, 2018
- Child seen at least once in consultation or hospitalization by a pediatrician member of the Society of Pediatric Nephrology
- Residing in France
- Consent signed by parents and patient's agreement to participate (if of age)
- Affiliated to a social security system
Who cannot take part
- Refusal of the patient or legal representatives to participate in the cohort
This trial is currently available in France and Réunion.
It has sites in 2 countries. Choose a country to see its sites.
About the trial
What the trial wants to find out
Pediatric idiopathic nephrotic syndrome (INS) is a rare disease for which the optimal therapeutic strategy has not yet been defined. A network of clinicians treating complicated forms of this disease (grouped within the Société de Néphrologie Pédiatrique, SNP) exists, but to date there is no prospective cohort following up these patients that would facilitate the development of cohort-nested trials. This absence of structured follow up makes it difficult to set up prospective studies.
Read full original descriptionShow less
The main objective is to create a prospective cohort of pediatric INS patients to collect cases treated in SNP centers, to study their epidemiological characteristics, and to provide a basis for comparison for future cohort-nested trials.
The group in the trial
- Inclusion and follow up of pediatric patients
Inclusion and follow up of pediatric patients with an idiopathic nephrotic syndrome, from the beginning of the disease to 18 years old or transfer of the follow-up to a nephrology unit for adults. 130 new patients are expected to be included on an annual basis.
Treatment: Inclusion and follow up of pediatric patients with an idiopathic nephrotic syndrome,
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A National Prospective Cohort of Patients With Idiopathic Nephrotic Syndrome Beginning in Childhood.
- Plain-language title
- National follow-up group of children with idiopathic nephrotic syndromeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Publications
- Record updated
- 13 March 2026